Redeye: OXE Marine - Capital injection
Redeye is glad to see that OXE Marine managed to raise ~SEK30m in a directed share issue. Subscription price of SEK1.0 per share is a rather modest discount of 8%. Several existing, and a number of new investors participated in the issue, which signals firm support from shareholders. Dilution for remaining owners is less than 10%.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/